- Home
- IMNM vs SPNT Comparison
IMNM vs SPNT Comparison
Compare IMNM & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | SPNT |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | SPNT |
|---|---|---|
| Price | $22.66 | $19.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $31.22 | $24.00 |
| AVG Volume (30 Days) | ★ 2.5M | 731.8K |
| Earning Date | 11-06-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | $9,679,000.00 | ★ $2,859,100,000.00 |
| Revenue This Year | N/A | $0.89 |
| Revenue Next Year | $11.53 | $6.87 |
| P/E Ratio | ★ N/A | $13.76 |
| Revenue Growth | N/A | ★ 6.92 |
| 52 Week Low | $5.15 | $13.26 |
| 52 Week High | $25.30 | $22.89 |
Technical Indicators
Market Signals| Indicator | IMNM | SPNT |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 38.01 |
| Support Level | $20.05 | $19.72 |
| Resistance Level | $22.01 | $20.59 |
| Average True Range (ATR) | 1.28 | 0.59 |
| MACD | 0.04 | -0.20 |
| Stochastic Oscillator | 82.00 | 9.38 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.